この製品に関するご意見・ご照会・お問合せはこちら

Research news

Advances in delivery of mRNA by lipid nanoparticles

New research explores the potential of lipid nanoparticles (LNPs) for mRNA delivery in vaccines and therapeutics, highlighting advancements in immunogenicity, tissue specificity, and targeted delivery. Studies demonstrate the development of LNPs with improved safety profiles for enhancing immune responses and reducing off-target effects. Exciting innovations in in vivo editing of hematopoietic stem cells offer promising avenues for treating genetic disorders, potentially revolutionizing current treatment approaches.

Our latest advancements

Discover our new tools and products

OligoBuilder® tool Engineered to expedite the delivery of complex oligonucleotide constructs, including heavily modified sequences—TriLink's specialty—our new OligoBuilder® tool empowers you to get the oligos you need to focus on your research. Build my oligos  ➔